Drugs / DA-9601
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT07139886 | Mar 1997 → Jul 1999 | chronic gastritis | Dong-A ST Co., Ltd. | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2002-10-31 | Dong-A ST Co., Ltd. | Results Best Paper at United European Gastroenterology Week donga-st.com ↗
Through macroscopic, structural, and molecular biological observation, Mr. Oh confirmed Stillen®’s (DA-9601) protection of the gastric mucosa against damage from alcohol. |
All press releases naming this drug 1 release
| Date | Issuer | Release |
|---|---|---|
| 2002-10-31 | Dong-A ST Co., Ltd. | Best Paper at United European Gastroenterology Week donga-st.com ↗ |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DA-9601 | “This is a multicenter, placebo-controlled, randomized, double-blinded, paralleled group clinical study to evaluate the efficacy of 2-week treatment with DA-9601 tab in patients...” NCT07139886 ↗ |